Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Inclusion Criteria: * Suspected preoperative diagnosis of invasive epithelial ovarian cancer, primary peritoneal carcinoma, fallopian tube cancer based on imaging and cancer antigen (Ca) 125; histologic epithelial cell types are eligible: serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell carcinoma, mixed epithelial carcinoma, or adenocarcinoma not otherwise specified; patients with primarily carcinoma histology but mixed features can be included; the surgically confirmed histologic features must be compatible with primary Mullerian epithelial adenocarcinoma * Stages II-IV of the above cancer * Patients to be scheduled for a planned tumor debulking * Intention for chemotherapy administration at MD Anderson Cancer Center * Zubrod performance status 0-2 * Absolute neutrophil count (ANC) \>= 1500/ml * Platelets \> 100,000/mL * Creatinine clearance (CrCl) \> 50 mL/min * Bilirubin =\< 1.5 x institutional upper limit normal * Serum glutamic oxaloacetic transaminase (SGOT) =\< 2.5 x institutional upper limit normal * Alkaline phosphatase =\< 2.5 x institutional upper limit normal * Neuropathy (sensory and motor) =\< grade 1 according to Common Toxicity Criteria for Adverse Events version 3 (CTCAE) * Prothrombin time (PT) such that international normalized ratio (INR) is =\< 1.5 (or an in-range INR, usually between 2 and 3, if a patient is on a stable dose of therapeutic warfarin for the management of venous thrombosis…